Cell line name | SBC-3/ADM | |
---|---|---|
Accession | CVCL_M841 | |
Resource Identification Initiative | To cite this cell line use: SBC-3/ADM (RRID:CVCL_M841) | |
Comments | Population: Japanese. Doubling time: 22 hours (PubMed=3012965); 45.9 hours (PubMed=10628341). Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). | |
Disease | Lung small cell carcinoma (NCIt: C4917) Small cell lung cancer (ORDO: Orphanet_70573) Derived from metastatic site: Bone marrow. | |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
| |
Hierarchy | Parent: CVCL_1678 (SBC-3) Children:
| |
Sex of cell | Male | |
Age at sampling | 24Y | |
Category | Cancer cell line | |
Publications | PubMed=3012965; DOI=10.18926/AMO/31923 PubMed=3012966; DOI=10.18926/AMO/31920 PubMed=3032107 PubMed=8104372; DOI=10.18926/AMO/31598 PubMed=10628341 | |
Cross-references | ||
Encyclopedic resources | Wikidata; Q54952169 | |
Entry history | ||
Entry creation | 05-Nov-2013 | |
Last entry update | 29-Oct-2020 | |
Version number | 12 |